Journal Title：Prostate Cancer

Prostate Cancer is an international peer-reviewed open access journal dedicated to prostate cancer research, providing a multidisciplinary platform for medical professionals to share and exchange the latest scientific research in the field of prostate cancer. The publication of the journal reflects the importance of prostate cancer as one of the major threats to men's health and the urgent need for further research in this area.

The reader and author community of the journal includes urologists, oncologists, radiation oncologists, pathologists, biomedical researchers, and scholars and students in related fields. By publishing original research, review articles, and clinical studies, the journal promotes not only the basic science of prostate cancer, but also the innovation and improvement of clinical treatment strategies. It covers everything from molecular biology, genetics, and epidemiological studies to clinical trials, evaluation of treatment outcomes, and patient management. It pays special attention to the early diagnosis of prostate cancer, precision treatment, improvement of patients' quality of life and long-term follow-up research, aiming to improve the comprehensive understanding of prostate cancer occurrence, development and treatment through interdisciplinary cooperation.

《前列腺癌》是一本致力于前列腺癌研究的國際同行評審開放獲取期刊，它為廣大醫(yī)學專業(yè)人士提供了一個分享和交流前列腺癌領(lǐng)域最新科研成果的多學科平臺。該期刊的出版，反映了前列腺癌作為男性健康主要威脅之一的重要性，以及對這一領(lǐng)域深入研究的迫切需求。

期刊的讀者和作者群體包括泌尿外科醫(yī)生、腫瘤科醫(yī)生、放射腫瘤學家、病理學家、生物醫(yī)學研究人員以及相關(guān)領(lǐng)域的學者和學生。通過發(fā)表原創(chuàng)研究、綜述文章和臨床研究，該期刊不僅促進了前列腺癌基礎(chǔ)科學的發(fā)展，也推動了臨床治療策略的創(chuàng)新和改進。內(nèi)容覆蓋了從分子生物學、遺傳學、流行病學研究到臨床試驗、治療結(jié)果評估和患者管理等多個方面。它特別關(guān)注前列腺癌的早期診斷、精準治療、患者生活質(zhì)量的提升以及長期跟蹤研究，旨在通過跨學科合作，提高對前列腺癌發(fā)生、發(fā)展和治療的全面認識。

Prostate Cancer由Hindawi Limited出版商出版，收稿方向涵蓋ONCOLOGY全領(lǐng)域，平均審稿速度 13 Weeks ，影響因子指數(shù)2.3，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學者值得一試。